LEXICON
No.102 February 13, 2012

In vitro diagnostic (IVD); extracorporeal diagnostic (agent)
体外診断薬(体外診断用医薬品)
In vivo diagnostic (agent)
体内診断薬
Laboratory study; clinical test; clinical assay
臨床検査
Laboratory (lab) test
検体検査
Physiological function test
生理機能検査

The Pharmaceutical Affairs Law (PAL; 薬事法) defines in vitro (extracorporeal) diagnostic agents (commonly 体外診断薬 and 体外診断用医薬品 in the PAL) as “drugs which are intended to be solely used to diagnose diseases and which are not directly applied to or introduced...

To read the full story

LEXICON

Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…

By Tatsuya Otsuka

Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…

By Philip Carrigan

We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…

Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…

By Ken Yoshino

The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…